WHAT AGING CLAIMS REST ON
What Aging Tests Show, and What They Leave Open
Do these substances help people live longer? Neither has proved that. Studies measured blood changes, muscle sugar use, and movement. You can see how far those findings reach.
What NAD+ supports in cells
NAD+ supports energy and repairs within cells. Levels can fall with age. Human testing raised NAD+ measured in blood. Longer life hasn't been established by those changes. Your health question remains open.
Blood tests of NAD+ →
What MOTS-c tests found in muscle
MOTS-c is a 16-amino-acid peptide, with small pieces joined as in proteins. The body's energy-producing cell parts make MOTS-c. Mice moved better in tests. Treatment hasn't been tested in people.
Movement tests of MOTS-c →What the early results can tell you
NAD+ and MOTS-c research hasn't proved that either extends human life. Some studies found changes that deserve closer testing. Other studies examined cells, tiny parts that make up a living body. Cells need fuel and repairs to keep doing their jobs. Aging may change how well cells manage those jobs. Researchers ask whether NAD+ or MOTS-c can help with those changes. An improvement measured in mice concerns those animals alone. Cells grown in dishes answer questions about cell work. Neither kind of test establishes what happens to an older person.
More healthy years remain a hope, rather than a demonstrated benefit.
AgeDefy Peptides describes those studies, with their limits alongside the results. Human research includes blood tests and some tests of movement. Animal experiments ask different questions and have different safety limits. You can read who received each substance and what changed. Neither substance has an approved aging use with an established amount. These pages supply research reading and no personal treatment advice. No products or instructions for treating yourself are offered here.
How peptides can affect work inside your body
A peptide contains joined amino acids; proteins contain those small parts too. Proteins have more pieces; peptides have fewer joined together. Some peptides are hormones, substances the body releases to carry messages. A hormone can travel in blood and change another organ's work. Other peptides carry messages inside a single cell. Researchers ask whether changing these messages might affect aging. The question concerns how the body works, beyond outward signs.
A substance made for research hasn't necessarily passed medicine safety checks.
Laboratory work can test animals, or examine cells growing in dishes. Some substances also reach trials with people taking part. These stages answer different questions about effects and possible harm. Strong human findings still do not replace the full approval checks. Early animal findings leave even more questions about human safety. A research label therefore gives no assurance about safe treatment. The body already makes some substances that scientists study. Adding more still needs testing for benefits and harms.
What blood and movement tests changed
Human treatment trials exist for NAD+, while MOTS-c has animal tests. NAD+ supports food being turned into cell fuel and supports repairs. Some repairs involve DNA, the instructions that guide a cell's work. NAD+ also affects inflammation, which is part of how your body handles injury or illness. Some older body parts contain less NAD+, but human findings remain limited [4]. The finding doesn't mean every organ loses the same amount. NMN and NR are substances that your body converts into NAD+. Human studies of both have found rises in blood NAD+ [1][2][3].
The blood result leaves health in the rest of your body unsettled.
MOTS-c is a 16-amino-acid peptide; proteins contain the same small parts. Its instructions occupy a DNA stretch called 12S inside energy-making cell parts. MOTS-c was the first peptide from those parts shown reaching the nucleus, where most cell DNA is held [10]. That finding concerns messages within cells, rather than an aging treatment. Exercise raises the body's own MOTS-c levels in muscle and blood. Older mice given extra MOTS-c performed better in movement tests. In people needing blood-filtering treatment, higher blood MOTS-c meant greater health risks [7][9].
The blood link doesn't establish that extra MOTS-c protects you.
NAD+ studies ask whether replacing a substance helps with energy and repairs. MOTS-c studies examine muscle work and messages sent during energy shortages. The comparison of their findings explains the different tests and remaining gaps.
What the small study numbers mean for you
Numbers beside findings point to the published study list. Papers identify who took part or which animals or cells were examined. A review gathers earlier findings; a trial runs a new test. A result from one laboratory still needs checking elsewhere.
An interesting study can leave your health question unanswered.
Animal improvements don't establish improvements for people receiving treatment. Blood results don't show whether people live longer or avoid disease. Tests of cells help explain body work without establishing patient benefits. These differences matter when you read claims about aging. The papers offer evidence to examine, rather than personal treatment instructions.